Wang Q - Search Results

1

Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib.

Zhu L, Chen Z, Zang H, Fan S, Gu J, Zhang G, Sun KD, Wang Q, He Y, Owonikoko TK, Ramalingam SS, Sun SY. Zhu L, et al. Among authors: wang q. Cancer Res. 2021 Sep 15;81(18):4822-4834. doi: 10.1158/0008-5472.CAN-21-0556. Epub 2021 Jul 21. Cancer Res. 2021. PMID: 34289988 Free PMC article.

2

A Case of Novel Inversion Mutation of EGFR Exon 19 Leading to Primary Resistance to EGFR TKIs in Lung Adenocarcinoma.

Li S, Zhao J, Wang Q. Li S, et al. Among authors: wang q. J Thorac Oncol. 2018 Jun;13(6):e97-e101. doi: 10.1016/j.jtho.2017.12.014. Epub 2018 Feb 28. J Thorac Oncol. 2018. PMID: 29501421 Free article. No abstract available.

3

Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells.

Wu Y, He Z, Li S, Tang H, Wang L, Yang S, Dong B, Qin J, Sun Y, Yu H, Zhang Y, Zhang Y, Guo Y, Wang Q. Wu Y, et al. Among authors: wang l, wang q. Curr Cancer Drug Targets. 2019;19(10):796-806. doi: 10.2174/1568009619666190103122735. Curr Cancer Drug Targets. 2019. PMID: 30605061

4

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer.

Wang Q, Yang S, Wang K, Sun SY. Wang Q, et al. Among authors: wang k. J Hematol Oncol. 2019 Jun 21;12(1):63. doi: 10.1186/s13045-019-0759-9. J Hematol Oncol. 2019. PMID: 31227004 Free PMC article. Review.

5

The impact of previous therapy strategy on the efficiency of anlotinib hydrochloride as a third-line treatment on patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis of ALTER0303 trial.

Wang L, He Z, Yang S, Tang H, Wu Y, Li S, Han B, Li K, Zhang L, Shi J, Wang Z, Cheng Y, He J, Shi Y, Chen W, Luo Y, Wu L, Wang X, Nan K, Jin F, Dong J, Li B, Sun Y, Wang Q. Wang L, et al. Among authors: wang x, wang z, wang q. Transl Lung Cancer Res. 2019 Oct;8(5):575-583. doi: 10.21037/tlcr.2019.09.21. Transl Lung Cancer Res. 2019. PMID: 31737494 Free PMC article.

6

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer.

Zhang Z, Yang S, Wang Q. Zhang Z, et al. Among authors: wang q. Biomark Res. 2019 Nov 21;7:27. doi: 10.1186/s40364-019-0179-6. eCollection 2019. Biomark Res. 2019. PMID: 31832192 Free PMC article. Review.

7

Dynamic changes of acquired T790M mutation and small cell lung cancer transformation in a patient with EGFR-mutant adenocarcinoma after first- and third-generation EGFR-TKIs: a case report.

Ma S, He Z, Fu H, Wang L, Wu X, Zhang Z, Wang Q. Ma S, et al. Among authors: wang l, wang q. Transl Lung Cancer Res. 2020 Feb;9(1):139-143. doi: 10.21037/tlcr.2020.01.07. Transl Lung Cancer Res. 2020. PMID: 32206560 Free PMC article.

8

Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.

Wu YL, Tsuboi M, He J, John T, Grohe C, Majem M, Goldman JW, Laktionov K, Kim SW, Kato T, Vu HV, Lu S, Lee KY, Akewanlop C, Yu CJ, de Marinis F, Bonanno L, Domine M, Shepherd FA, Zeng L, Hodge R, Atasoy A, Rukazenkov Y, Herbst RS; ADAURA Investigators. Wu YL, et al. N Engl J Med. 2020 Oct 29;383(18):1711-1723. doi: 10.1056/NEJMoa2027071. Epub 2020 Sep 19. N Engl J Med. 2020. PMID: 32955177 Clinical Trial.

9

Coexistence of a novel CCNY-ALK and ATIC-ALK double-fusion in one patient with ALK-positive NSCLC and response to crizotinib: a case report.

Wu X, Zhou H, He Z, Zhang Z, Feng W, Zhao J, Chen H, Wang S, Wang W, Wang Q. Wu X, et al. Among authors: wang w, wang s, wang q. Transl Lung Cancer Res. 2020 Dec;9(6):2494-2499. doi: 10.21037/tlcr-20-1049. Transl Lung Cancer Res. 2020. PMID: 33489809 Free PMC article.

10

Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosis.

Zhang S, Chen Z, Shi P, Fan S, He Y, Wang Q, Li Y, Ramalingam SS, Owonikoko TK, Sun SY. Zhang S, et al. Among authors: wang q. Theranostics. 2021 Feb 15;11(8):3964-3980. doi: 10.7150/thno.54824. eCollection 2021. Theranostics. 2021. PMID: 33664875 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68,878 results

Search Page